Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Archives of Disease in Childhood|July 26, 2006
Combined ultrasound and isotope scanning is more informative in the diagnosis of congenital hypothyroidism than single scanningR J Perry, S Maroo, A C Maclennan, et al.
British Journal of Haematology|June 1, 1993
Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trialR D Brown, D E Joshua, M Nelson, et al.
European Journal of Immunology|January 1, 1984
Marginal zone B cells express CR1 and CR2 receptorsD Gray, I McConnell, D S Kumararatne, et al.
British Journal of Haematology|July 10, 2001
Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myelomaE V McCloskey, J A Dunn, J A Kanis, et al.
British Journal of Haematology|May 12, 1998
MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma. MRC Working Party on Leukaemia in AdultsM T Drayson, C E Chapman, J A Dunn, et al.
European Journal of Immunology|May 6, 1999
T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular fociC García de Vinuesa, P O'Leary, D M Sze, et al.
Clinical and Experimental Immunology|August 1, 1975
Reversible granulocyte killing defect in anorexia nervosaF M Gotch, C J Spry, A G Mowat, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Renal failure in myelomatosisI C MacLennan, E H Cooper, C E Chapman, et al.
British Journal of Cancer|December 1, 1985
Urinary pseudouridine excretion in myelomatosisS H Sørensen, D A Brown, E H Cooper, et al.
International Journal of Cancer|January 15, 1989
A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissuesN R Ling, D Hardie, J Lowe, et al.
Pageof 16